OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Enzalutamide-induced signatures revealed by epigenetic plasticity using single-cell multi-omics sequencing in prostate cancer
Huihui Fan, Jinze Li, Astrid M. Manuel, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 648-661
Open Access | Times Cited: 7
Huihui Fan, Jinze Li, Astrid M. Manuel, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 648-661
Open Access | Times Cited: 7
Showing 7 citing articles:
Basal–epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer
Mohammed Inayatullah, Arun Mahesh, Arran Turnbull, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 823-853
Open Access | Times Cited: 5
Mohammed Inayatullah, Arun Mahesh, Arran Turnbull, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 823-853
Open Access | Times Cited: 5
The kinase PLK1 promotes Hedgehog signaling–dependent resistance to the antiandrogen enzalutamide in metastatic prostate cancer
Qiongsi Zhang, Jia Peng, Yanquan Zhang, et al.
Science Signaling (2025) Vol. 18, Iss. 878
Closed Access
Qiongsi Zhang, Jia Peng, Yanquan Zhang, et al.
Science Signaling (2025) Vol. 18, Iss. 878
Closed Access
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Dongxu Zhang, Pu Liang, Bowen Xia, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Dongxu Zhang, Pu Liang, Bowen Xia, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
What should be the future direction of development in the field of prostate cancer with lung metastasis?
Zhi‐Guang Huang, Yi Chen, Tong Wu, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 10, pp. 420-439
Open Access | Times Cited: 2
Zhi‐Guang Huang, Yi Chen, Tong Wu, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 10, pp. 420-439
Open Access | Times Cited: 2
Single-cell technology for drug discovery and development
A Zhang, Jiawei Zou, Yue Xi, et al.
Frontiers in Drug Discovery (2024) Vol. 4
Open Access
A Zhang, Jiawei Zou, Yue Xi, et al.
Frontiers in Drug Discovery (2024) Vol. 4
Open Access
Application and new findings of scRNA-seq and ST-seq in prostate cancer
Li Zhuang, Zhengnan Li, Yuanyuan Luo, et al.
Cell Regeneration (2024) Vol. 13, Iss. 1
Open Access
Li Zhuang, Zhengnan Li, Yuanyuan Luo, et al.
Cell Regeneration (2024) Vol. 13, Iss. 1
Open Access
Steroid receptor-assisted loading modulates transcriptional responses in prostate cancer cells
Johannes Hiltunen, Laura Helminen, Niina Aaltonen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Johannes Hiltunen, Laura Helminen, Niina Aaltonen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
